Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics
暂无分享,去创建一个
V. P. Collins | S. Tavaré | J. Marioni | C. Curtis | I. Spiteri | A. Sottoriva | S. Piccirillo | Anestis Touloumis | C. Watts | V. Collins | Andrea Sottoriva | Simon Tavaré
[1] A. Álvarez-Buylla,et al. Neurogenesis in the Adult Brain I , 2011 .
[2] Zhongming Zhao,et al. Uncovering MicroRNA and Transcription Factor Mediated Regulatory Networks in Glioblastoma , 2012, PLoS Comput. Biol..
[3] T. Sano,et al. Loss of chromosome 10 in glioblastoma: Relation to proliferation and angiogenesis , 1999, Pathology international.
[4] K. Aldape,et al. The Use of Global Profiling in Biomarker Development for Gliomas , 2011, Brain pathology.
[5] P. Diegelman,et al. Methylthioadenosine phosphorylase, a gene frequently codeleted with p16(cdkN2a/ARF), acts as a tumor suppressor in a breast cancer cell line. , 2002, Cancer research.
[6] K. Polyak,et al. Tumor heterogeneity: causes and consequences. , 2010, Biochimica et biophysica acta.
[7] S. Tavaré,et al. Investigating stem cells in human colon by using methylation patterns , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[8] S. Gabriel,et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. , 2010, Cancer cell.
[9] Simon Tavaré,et al. Integrating Approximate Bayesian Computation with Complex Agent-Based Models for Cancer Research , 2010, COMPSTAT.
[10] E. Lander,et al. Assessing the significance of chromosomal aberrations in cancer: Methodology and application to glioma , 2007, Proceedings of the National Academy of Sciences.
[11] A. Børresen-Dale,et al. The Life History of 21 Breast Cancers , 2012, Cell.
[12] Francisco Tirado,et al. GeneCodis: interpreting gene lists through enrichment analysis and integration of diverse biological information , 2009, Nucleic Acids Res..
[13] J. Griffiths,et al. Fluorescence-guided surgical sampling of glioblastoma identifies phenotypically distinct tumour-initiating cell populations in the tumour mass and margin , 2012, British Journal of Cancer.
[14] Bernardo Celda,et al. New pattern of EGFR amplification in glioblastoma and the relationship of gene copy number with gene expression profile , 2010, Modern Pathology.
[15] K. Polyak,et al. Intra-tumour heterogeneity: a looking glass for cancer? , 2012, Nature Reviews Cancer.
[16] Kenric Leung,et al. The Life History of 21 Breast Cancers , 2015, Cell.
[17] C. Maley,et al. Cancer is a disease of clonal evolution within the body1–3. This has profound clinical implications for neoplastic progression, cancer prevention and cancer therapy. Although the idea of cancer as an evolutionary problem , 2006 .
[18] Joshua M. Korn,et al. Comprehensive genomic characterization defines human glioblastoma genes and core pathways , 2008, Nature.
[19] F. Cleton. Evolution of Cancer , 1991, British Journal of Cancer.
[20] J. Troge,et al. Inferring tumor progression from genomic heterogeneity. , 2010, Genome research.
[21] F. Zanella,et al. Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. , 2006, The Lancet. Oncology.
[22] S. McWeeney,et al. Cancer stem cell tumor model reveals invasive morphology and increased phenotypical heterogeneity. , 2010, Cancer research.
[23] D P Byar,et al. Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. , 1980, The New England journal of medicine.
[24] Charles Swanton,et al. Intratumor Heterogeneity: Seeing the Wood for the Trees , 2012, Science Translational Medicine.
[25] M. Nowak,et al. Distant Metastasis Occurs Late during the Genetic Evolution of Pancreatic Cancer , 2010, Nature.
[26] Zhihui Xie,et al. Nuclear Factor of Activated T Cells (NFAT) Proteins Repress Canonical Wnt Signaling via Its Interaction with Dishevelled (Dvl) Protein and Participate in Regulating Neural Progenitor Cell Proliferation and Differentiation* , 2011, The Journal of Biological Chemistry.
[27] P. A. Futreal,et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. , 2012, The New England journal of medicine.
[28] Andrea Sottoriva,et al. Single-molecule genomic data delineate patient-specific tumor profiles and cancer stem cell organization. , 2013, Cancer research.
[29] J. Salk. Clonal evolution in cancer , 2010 .
[30] Debyani Chakravarty,et al. Intratumoral heterogeneity of receptor tyrosine kinases EGFR and PDGFRA amplification in glioblastoma defines subpopulations with distinct growth factor response , 2012, Proceedings of the National Academy of Sciences.
[31] E. Letouzé,et al. Analysis of the copy number profiles of several tumor samples from the same patient reveals the successive steps in tumorigenesis , 2010, Genome Biology.
[32] Simon Tavaré,et al. The Stem Cell Population of the Human Colon Crypt: Analysis via Methylation Patterns , 2007, PLoS Comput. Biol..
[33] Peter J. Campbell,et al. Evolution of the cancer genome , 2012, Nature Reviews Genetics.
[34] Simon Tavaré,et al. Modeling Evolutionary Dynamics of Epigenetic Mutations in Hierarchically Organized Tumors , 2011, PLoS Comput. Biol..
[35] N G Burnet,et al. Years of life lost (YLL) from cancer is an important measure of population burden – and should be considered when allocating research funds , 2005, British Journal of Cancer.
[36] J. Uhm. Comprehensive genomic characterization defines human glioblastoma genes and core pathways , 2009 .
[37] R. Gillies,et al. Evolutionary dynamics of carcinogenesis and why targeted therapy does not work , 2012, Nature Reviews Cancer.
[38] Rebecca A Betensky,et al. Mosaic amplification of multiple receptor tyrosine kinase genes in glioblastoma. , 2011, Cancer cell.
[39] Satoshi Ota,et al. NLK positively regulates Wnt/β‐catenin signalling by phosphorylating LEF1 in neural progenitor cells , 2012, The EMBO journal.
[40] V P Collins,et al. Human glioblastomas with no alterations of the CDKN2A (p16INK4A, MTS1) and CDK4 genes have frequent mutations of the retinoblastoma gene. , 1996, Oncogene.
[41] Martin J. van den Bent,et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. , 2005, The New England journal of medicine.
[42] C. Perou,et al. Allele-specific copy number analysis of tumors , 2010, Proceedings of the National Academy of Sciences.
[43] A. Levine,et al. The Control of the Metabolic Switch in Cancers by Oncogenes and Tumor Suppressor Genes , 2010, Science.
[44] Paul Marjoram,et al. Inferring clonal expansion and cancer stem cell dynamics from DNA methylation patterns in colorectal cancers , 2009, Proceedings of the National Academy of Sciences.
[45] Thomas D. Wu,et al. Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. , 2006, Cancer cell.